US Stock MarketDetailed Quotes
BCTX BriaCell Therapeutics
- 2.240
- +0.050+2.28%
Close Apr 25 16:00 ET
- 2.320
- +0.080+3.57%
Post 18:25 ET
35.80MMarket Cap-2835P/E (TTM)
2.260High2.150Low29.09KVolume2.150Open2.190Pre Close64.32KTurnover0.25%Turnover RatioLossP/E (Static)15.98MShares7.59052wk High-4.44P/B26.07MFloat Cap2.01052wk Low--Dividend TTM11.64MShs Float12.470Historical High--Div YieldTTM5.02%Amplitude2.010Historical Low2.211Avg Price1Lot Size
BriaCell Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | (Q3)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M | -28.33%41.04M | -28.33%41.04M | 121.78%44.53M |
| -Cash and cash equivalents | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M | -28.33%41.04M | -28.33%41.04M | 121.78%44.53M |
| Receivables | 237.65%30.15K | -27.91%21.41K | -21.70%18.87K | -21.70%18.87K | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K | 91.69%24.1K | 91.69%24.1K | -8.09%14.53K |
| -Accounts receivable | 237.65%30.15K | -27.91%21.41K | -21.70%18.87K | -21.70%18.87K | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K | 91.69%24.1K | 91.69%24.1K | -8.09%14.53K |
| Prepaid assets | 1,173.25%5.47M | 538.81%4.74M | 343.31%5.68M | 343.31%5.68M | -21.78%1.32M | 39.93%429.4K | 82.44%742.12K | 147.82%1.28M | 147.82%1.28M | 138.58%1.68M |
| Total current assets | -65.40%11.74M | -51.84%18.41M | -36.36%26.95M | -36.36%26.95M | -36.18%29.5M | -29.76%33.94M | -31.64%38.22M | -26.73%42.35M | -26.73%42.35M | 122.25%46.23M |
| Non current assets | ||||||||||
| Goodwill and other intangible assets | -6.86%207.43K | -6.74%211.25K | -6.63%215.07K | -6.63%215.07K | -6.52%218.89K | -6.42%222.7K | -6.32%226.52K | -6.22%230.34K | -6.22%230.34K | -6.18%234.16K |
| -Other intangible assets | ---- | ---- | -6.63%215.07K | -6.63%215.07K | ---- | ---- | ---- | -6.22%230.34K | -6.22%230.34K | -6.18%234.16K |
| Investments and advances | 14,082,750.00%281.66K | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 22.77%2 |
| Total non current assets | 119.61%489.09K | -6.74%211.25K | -6.63%215.07K | -6.63%215.07K | -6.52%218.89K | -6.42%222.71K | -6.32%226.52K | -6.22%230.34K | -6.22%230.34K | -6.18%234.16K |
| Total assets | -64.20%12.23M | -51.58%18.62M | -36.20%27.16M | -36.20%27.16M | -36.03%29.72M | -29.64%34.16M | -31.53%38.45M | -26.65%42.58M | -26.65%42.58M | 120.73%46.46M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 537.21%3.71M | -45.20%433.92K | 142.56%1.12M | 142.56%1.12M | --995.25K | --582.45K | --791.75K | 57.00%463.28K | 57.00%463.28K | ---- |
| -accounts payable | 537.21%3.71M | -45.20%433.92K | 142.56%1.12M | 142.56%1.12M | --995.25K | --582.45K | --791.75K | 116.37%463.28K | 116.37%463.28K | ---- |
| Current accrued expenses | 142.00%212.87K | 236.03%612.59K | 41.84%677.72K | 41.84%677.72K | --387.84K | --87.96K | --182.3K | 82.57%477.81K | 82.57%477.81K | ---- |
| Current liabilities | 485.36%3.92M | 7.44%1.05M | 91.42%1.8M | 91.42%1.8M | 277.59%1.38M | 10.78%670.41K | 125.81%974.05K | 69.02%941.09K | 69.02%941.09K | 115.63%366.29K |
| Non current liabilities | ||||||||||
| Derivative product liabilities | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,763.43%27.14M | 5.09%31.31M | 5.09%31.31M | -95.97%278.4K |
| Total non current liabilities | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,046.13%27.14M | 5.00%31.31M | 5.00%31.31M | -96.06%278.4K |
| Total liabilities | -42.02%20.55M | -42.73%16.1M | -4.05%30.94M | -4.05%30.94M | 5,424.26%35.61M | 4,051.87%35.44M | 3,577.44%28.12M | 6.18%32.25M | 6.18%32.25M | -91.08%644.69K |
| Shareholders'equity | ||||||||||
| Share capital | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M | 19.74%65.59M | 19.74%65.59M | 120.84%55.85M |
| -common stock | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M | 19.74%65.59M | 19.74%65.59M | 120.84%55.85M |
| Retained earnings | -17.19%-85.95M | -21.47%-74.65M | -33.64%-80.65M | -33.64%-80.65M | -183.63%-78.23M | -222.24%-73.34M | -238.78%-61.46M | -107.09%-60.35M | -107.09%-60.35M | -96.92%-27.58M |
| Paid-in capital | ---- | 24.90%7.92M | 41.96%7.42M | 41.96%7.42M | --6.89M | --6.61M | --6.34M | 140.03%5.23M | 140.03%5.23M | ---- |
| Gains losses not affecting retained earnings | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | -62.20%-138.68K |
| Other equity interest | --8.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 574.83%17.69M |
| Total stockholders'equity | -530.42%-8.07M | -73.67%2.72M | -136.57%-3.78M | -136.57%-3.78M | -112.86%-5.89M | -102.68%-1.28M | -81.34%10.33M | -62.67%10.33M | -62.67%10.33M | 231.54%45.82M |
| Noncontrolling interests | ---244.42K | ---205.11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total equity | -549.50%-8.32M | -75.65%2.52M | -136.57%-3.78M | -136.57%-3.78M | -112.86%-5.89M | -102.68%-1.28M | -81.34%10.33M | -62.67%10.33M | -62.67%10.33M | 231.54%45.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg